Search results
Showing 7906 to 7920 of 8901 results
This guideline has been updated and replaced by NICE guideline CG101.
This guidance has been updated and replaced by NICE guideline NG122.
Common mental health problems: identification and pathways to care (CG123)
We withdrew this guideline in May 2024, because all of the recommendations are now covered in other NICE guidelines, or are out of date and no longer relevant to clinical practice. For guidance on common mental health problems, see our guidelines on: Depression in adults Depression in adults with a chronic physical health problem Depression in children and young people Generalised anxiety disorder and panic disorder in adults Obsessive-compulsive disorder and body dysmorphic disorder Social anxiety disorder
Chronic kidney disease (stage 5): peritoneal dialysis (CG125)
This guidance has been updated and replaced by NICE guideline NG107.
Type 2 diabetes foot problems: Prevention and management of foot problems (CG10)
This guidance has been updated and replaced by NICE guideline NG19.
This guidance has been updated and replaced by NICE guideline CG82.
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (CG101)
This guideline has been updated and replaced by NICE guideline NG115.
This guideline has been updated and replaced by NICE guideline NG240.
This guideline has been updated and replaced by NICE guideline 42.
This guidance has been updated and replaced by NICE guideline NG231.
This guidance has been updated and replaced by NICE guideline NG133
This guideline has been updated and replaced by NICE guideline NG106.
October 2018: This process guide has been updated. The updated version can be found in the tools and resources for developing NICE guidelines: the manual.
Process manual for the endorsement of guidance and quality standard support resources (PMG29)
The endorsement programme is now closed and no new applications are being accepted. Information about existing endorsed resources, are available on the endorsement webpage. Please email endorsement@nice.org.uk if you have any queries.
Medicines optimisation: key therapeutic topics – Integrated process statement (PMG13)
February 2022: we have withdrawn our medicines optimisation: key therapeutic topics. We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy. If you have any queries, please contact nice@nice.org.uk.